Enter your details below for more information

What is 2 + 3?*


We will have a UK Network of ‘Best Practice' medical centres where specialists can prescribe or oversee prescriptions of Medicinal Cannabinoids.

Future Proof Investment Opportunity 

Medicaleaf™ intends to generate revenue in excess of £5.34 million in this first trading year.

Annual predicted net profit over sales metric of ‘plus 43%'.

Medicaleaf™ is aiming for a ‘post-raise' valuation of £20 million with expectations to reach a pre-floatation valuation of £100 million in three years' time.

Offset over 50% of your investment with CGT and EIS relief.

Minimum Investment £10,000.

“The CBD Industry Is Here To Stay” 

The information provided on this website is for information purposes only. The website and its content are not, and should not be deemed to be an offer of, or invitation to engage in any investment activity. The website should not be construed as advice, or a personal recommendation by Medicaleaf Ltd . Medicaleaf Ltd  is not authorised and regulated by the Financial Conduct Authority (FCA). The content of this promotion is not authorised under the Financial Services and Markets Act 2000 (FSMA). Reliance on the promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the investment. UK residents wishing to participate in this promotion must fall into the category of sophisticated investor or high net worth individual as outlined by the Financial Conduct Authority (FCA).